Physician profile
Faiz Bhora
NPI 1396791000
$255,139.93
in general payments reported to CMS, 2019-2025
49 companies · $33K in 2025
The $33K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $10K · 2021: $29K · 2022: $34K · 2023: $57K · 2024: $48K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Consulting Fee: $44K · Travel and Lodging: $21K · Food and Beverage: $13K · Honoraria: $3,800 · Education: $3,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,800.00 |
| Consulting Fee | $43,830.25 |
| Travel and Lodging | $20,756.29 |
| Food and Beverage | $12,879.44 |
| Honoraria | $3,800.00 |
| Education | $3,127.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $66,723.22 | 2021-2025 | Tagrisso, Imfinzi |
| Boston Scientific Corporation | $60,828.31 | 2019-2025 | Exalt Model D, Acquire, General - Angioplasty |
| Veran Medical Technologies, INC. | $32,316.04 | 2019-2020 | |
| Medical Device Business Services, INC. | $15,089.25 | 2020-2025 | Contour, Echelon Endopath, Matrixrib |
| Ambu INC. | $10,865.46 | 2022-2025 | |
| Elucent Medical | $10,523.33 | 2023-2025 | |
| Pulmonx Corporation | $9,957.67 | 2021-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Cmr Surgical, INC. | $9,268.18 | 2025 | Versius Surgical System (Versius Plus) |
| Ethicon US, LLC | $7,421.36 | 2019-2025 | Echelon Endopath, Echelon Flex, Monarch Platform |
| Intuitive Surgical, INC. | $6,084.53 | 2019-2025 | Ion, Da Vinci Surgical System |
| Genentech USA, INC. | $4,269.48 | 2022-2023 | |
| Ethicon INC. | $3,636.80 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $3,280.84 | 2024 | Opdivo, Augtyro |
| Noah Medical Corporation | $2,110.09 | 2023-2025 | Galaxy |
| Davol INC. | $1,923.34 | 2020-2025 | Progel Applicator Spray Tips, Arista |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $1,580.19 | 2019-2020 | |
| Synthes USA Products LLC | $1,508.73 | 2022 | |
| Medtronic, INC. | $1,250.51 | 2021-2024 | Signia, Thoracoport |
| Becton, Dickinson and Company | $761.43 | 2019-2024 | Phasix Mesh |
| Galvanize Therapeutics, INC | $553.65 | 2023-2024 | Aliya System |
| Dilon Technologies, INC. | $540.70 | 2023-2025 | Hemoblast Bellows |
| Merit Medical Systems INC | $490.51 | 2019-2025 | Esophyx, Aeromini Stent and Delivery System, Aero Stent and Delivery System |
| Depuy Synthes Sales INC. | $430.39 | 2019 | |
| Olympus America INC. | $399.91 | 2019-2021 | |
| Innocoll Pharmaceuticals Limited | $324.91 | 2023 | Xaracoll |
| Conmed Corporation | $304.14 | 2019-2025 | Airseal |
| Atricure, INC. | $298.95 | 2022-2024 | |
| Seapearl East, INC | $270.04 | 2024-2025 | |
| Bard Access Systems, INC. | $260.06 | 2019 | |
| Ge Healthcare | $212.00 | 2023 | |
| Lexington Medical, INC. | $197.75 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Inspire Medical Systems, INC. | $172.83 | 2023-2024 | Inspire |
| Ethicon Endo-Surgery INC. | $159.91 | 2020-2024 | Linx Reflux Management System, Echelon; Endopath |
| Activ Surgical, INC. | $136.81 | 2021 | |
| Foundation Medicine, INC. | $132.37 | 2022 | |
| Body Vision Medical INC. | $130.13 | 2022 | |
| Kls-Martin L.P. | $116.77 | 2019 | |
| Biom'Up France Sas | $107.45 | 2021 | |
| Surgical Theater. INC. | $97.36 | 2022 | |
| Pinnacle Biologics, INC | $95.89 | 2023-2024 | Photofrin |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $75.74 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $67.97 | 2023-2024 | Cios Spin |
| Regeneron Healthcare Solutions, INC. | $40.89 | 2024 | Libtayo |
| Zimmer Biomet Holdings, INC. | $30.38 | 2023 | Ribfix Blu Advantage, Medline |
| United Therapeutics Corporation | $29.85 | 2024 | Remodulin, Orenitram |
| Tela Bio, INC. | $17.66 | 2024 | Ovitex 2s |
| Merck Sharp & Dohme LLC | $16.48 | 2024 | Keytruda |
| Pacira Pharmaceuticals Incorporated | $15.63 | 2024 | Iovera, Exparel |
| Pharmaessentia USA Corporation | $14.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faiz Bhora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.